AI Image Analysis Co-founders’ Publication Accepted by European Heart Journal Digital Health

We’re excited to share that Octiocor’s groundbreaking automated OCT analysis system, AutoOCT™, has been selected for two oral presentations at EuroPCR 2025, Europe’s premier event for interventional cardiovascular medicine, including the prestigious Innovations session. EuroPCR brings together leading experts in cardiology and provides a powerful platform to showcase advancements that could shape the future of cardiovascular care.

The opportunity to present AutoOCT™ at EuroPCR is a significant milestone for Octiocor, as it underscores the growing recognition of our system’s potential to transform the field of cardiac imaging. AutoOCT™ woffers clinicians a faster, more accurate, and repeatable way to analyse OCT images, empowering them to make critical decisions with greater confidence.

We’re looking forward to the engaging discussions and feedback from thought leaders in the cardiovascular community. This recognition is not just a testament to the hard work of our team but also to the incredible promise of AutoOCT™ in improving patient care and advancing the future of interventional cardiology. Stay tuned for more exciting updates as we prepare for this incredible opportunity!

Octiocor is proud to announce that our cutting-edge automated OCT analysis system, AutoOCT™, was featured in the Innovations session at the prestigious 2024 International Transcatheter Therapeutics (TCT) meeting in Washington D.C. TCT is one of the most influential global forums for interventional cardiology, bringing together experts and innovators from across the world.

During the event, Octiocor co-founder and CMO Prof. Martin Bennett shared insights on the powerful capabilities of AutoOCT™, which will revolutionise the way clinicians analyse optical coherence tomography (OCT) images. As Martin Bennett said ‘We had a great response from both industry and potential funders that we’re currently exploring’, and Octiocor is currently exploring exciting opportunities to advance AutoOCT™ further, thanks to the invaluable connections made at TCT.

At Octiocor, we're committed to improving patient outcomes and advancing medical technology. With AutoOCT™, we’re making significant strides toward providing faster, more accurate diagnostic tools for cardiologists worldwide. Stay tuned for more updates as we continue to innovate and lead the way in cardiac imaging.

We are excited to share another significant milestone for Octiocor! Our cofounder, Professor Martin Bennett, will be presenting cutting-edge research on the automated analysis of OCT (Optical Coherence Tomography) images at the prestigious Vulnerable Plaque Meeting (VPM) in Sevilla, Spain.

About the Presentation

The presentation will highlight the Octiocor team’s innovative work on the development of advanced algorithms for the automated analysis of OCT images, particularly focusing on how these tools can detect vulnerable plaques, potentially life-threatening arterial conditions that can lead to heart attacks.

Through this research, Prof. Bennett and the team at Octiocor have developed a novel approach that enhances the accuracy, speed, and reliability of OCT image analysis. The ability to automatically detect and assess vulnerable plaques could dramatically improve early diagnosis, clinical decision-making, and ultimately patient outcomes. This advancement represents a significant leap in the application of AI and machine learning in medical imaging.

What this Means

The ability to detect vulnerable plaques earlier could revolutionise the way cardiologists and vascular specialists approach cardiovascular disease management. This presentation is particularly timely as the medical community continues to explore more effective methods for identifying at-risk patients, especially when traditional diagnostic methods can sometimes fall short.

At Octiocor, we are driven by our commitment to leveraging technology and research to tackle real-world health challenges. Presenting this work at an esteemed conference like the VPM reinforces our mission to transform healthcare through innovation, while also contributing to the broader academic and medical community.

Looking Ahead: The Future of Automated OCT Image Analysis

As this research evolves, Prof. Bennett and team will continue to lead the way in refining algorithms that integrate artificial intelligence with medical imaging. Our team is working tirelessly to bring these breakthroughs to the clinic, where they can provide tangible benefits to healthcare providers and patients alike.

The insights shared at this event will not only help shape future studies but also strengthen our collaborations with key industry partners. We are excited about the opportunities that lie ahead in medical imaging, and this presentation is a key part of that journey.

Join Us at the Vulnerable Plaque Meeting

If you’re attending the VPM in Sevilla, please message us directly at info@octiocor.com and don’t miss the opportunity to see Prof. Bennett’s presentation in person. We look forward to engaging with experts in the field and discussing how this research can drive progress in diagnosing and treating cardiovascular disease.

Stay tuned for more updates, and thank you for supporting Octiocor as we continue to push the limits of leveraging Artificial Intelligence and Computer Vision in the automated analysis of OCT images.

We are thrilled to announce a major milestone for Octiocor Ltd! Our founders, Professor Martin Bennett and Dr. Michael Roberts, have recently published a groundbreaking academic paper titled Correcting common OCT artifacts enhances plaque classification and identification of higher-risk plaque features, now available on PubMed. This publication represents a significant contribution to using computational techniques to help prevent future heart attacks and underscores our commitment to advancing knowledge and innovation in cardiovascular disease.

About the Paper

The paper delves into how various Artificial Intelligence and Computer Vision techniques can be used to remove or reduce artifacts (like blood cells) in OCT images, making human and automated analysis significantly more accurate. The research methodology, findings, and implications outlined in the paper are a testament to the expertise and passion that Martin and Mike bring to Octiocor. As pioneers in the field, our founders have always believed in the power of scientific research to drive innovation, and this publication serves as a testament to their vision.

Why This Matters

For Octiocor, this academic paper is not just an achievement, it's a reflection of our dedication to using cutting edge technology to solve real-world problems. The insights and knowledge generated from this research will play a crucial role in both improving the accuracy of our AutoOCT™ algorithms and shaping our future products and services. As a company that thrives on cutting-edge technology and research-driven solutions, this publication further validates our approach and sets us apart as leaders in the industry.

A Glimpse into the Future

This publication marks just the beginning of our journey. The findings and ideas shared in this paper will directly inform our upcoming innovations and partnerships. We are excited to leverage this academic foundation as we continue to develop solutions that are designed to transform automated analysis of OCT images to help prevent future heart attacks. We are incredibly proud of the hard work and dedication that went into this research, and we can't wait to share the impact of these findings with our community, partners, and customers.

Read the Full Paper

To learn more about this groundbreaking study, we invite you to read the full paper on PubMed - https://pubmed.ncbi.nlm.nih.gov/38971662/. Stay tuned for more updates, and thank you for supporting Octiocor as we continue to push the limits of leveraging Artificial Intelligence and Computer Vision in the automated analysis of OCT images.